Genova
Latest round
- Series A
Last raised
- May 2016
Total raised
- Undisclosed
Investors
- 1
About Genova
Founded in 2014 and headquartered in Changzhou, China, Genova specializes in biotechnology products for pharmaceuticals.Genova specializes in the development and manufacturing of cutting-edge biotechnology products aimed at addressing critical needs in pharmaceuticals and healthcare. The company’s core offerings include advanced drug formulations, manufacturing solutions, and contract development and manufacturing organization (CDMO) services. These products are designed to enhance the efficacy and safety of medications, addressing challenges faced by pharmaceutical companies in drug delivery and compliance. Genova serves a diverse clientele, which includes major pharmaceutical corporations and research institutions across North America, Europe, and parts of Asia.Genova's revenue is generated primarily through a structured transaction model that encompasses B2B partnerships and direct contracts with pharmaceutical clients. The company engages in long-term collaborations with its clients, focusing on providing tailored manufacturing and development services to meet specific pharmaceutical needs. Transactions often involve negotiated contracts that establish pricing plans based on the volume and complexity of services, including exclusive agreements for flagship products. These partnerships allow Genova to secure consistent revenue streams while maintaining a robust pipeline of innovative solutions. The company is working on launching several new drug formulations, with release dates targeting late 2024. Additionally, Genova has plans to penetrate new geographic markets, specifically aiming to establish a stronger presence in Europe and parts of Asia by the end of 2025.
Who invested in Genova
1 investor across 1 round
See all investors in Genova
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
May 24, 2016
Amount
Undisclosed
Investors
Questions about Genova
Who invested in Genova?
Genova has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Genova raised?
Genova has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Genova last raise money?
Genova's most recent round on record is a Series A, in May 2016.
What does Genova do?
Founded in 2014 and headquartered in Changzhou, China, Genova specializes in biotechnology products for pharmaceuticals.
Where is Genova headquartered?
Genova is headquartered in Changzhou, China.
Which VCs invest in companies like Genova?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Genova's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Genova? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.